Literature DB >> 21719351

Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation.

Roi Treister1, Dorit Pud, Richard P Ebstein, Efrat Laiba, Yael Raz, Edith Gershon, May Haddad, Elon Eisenberg.   

Abstract

UNLABELLED: Genetic studies have become indispensable in understanding pain mechanisms, shedding light on the role of monoamine pathways in pain modulation. The present study was aimed to explore the relationship between functional polymorphisms in serotonin and dopamine-related genes and pain modulation. Two paradigms of pain modulation were administered to 191 healthy participants in a random order: Conditioned Pain Modulation in response to painful stimuli (CPM(painful)) tested by the coadministration of repeated short painful heat stimuli and a conditioning tonic cold pain stimulation; and Conditioned Pain Modulation in response to nonpainful stimuli (CPM(nonpainful)) tested similarly, except for using a painless conditioning stimulation. Using the Transmission Disequilibrium Test (TDT), functional variable number of tandem repeat (VNTR) polymorphisms of the following candidate genes were studied: 1) serotonin transporter (5-HTTLPR); 2) dopamine transporter (DAT1); 3) dopamine receptor 4 (DRD4); and 4) monoamine oxidase A (MAOA). DNA samples from both participants and their parents were analyzed. A significant association was found between CPM(nonpainful) and the 5-HTTLPR polymorphism (P = .001). More specifically, carriers of the long allele exhibited a significantly higher magnitude of CPM(nonpainful) than carriers of the short allele. No associations were found between the dopamine-related genes and both types of pain modulation. These results highlight the importance of serotonin in endogenous analgesia. PERSPECTIVE: This article presents an association between the serotonin transporter gene polymorphism (5-HTTLPR) and pain modulation derived by nonpainful conditioned pain modulation (CPM(nonpainful)), rather than painful conditioned pain modulation (CPM(painful)). These findings emphasize the complex role of serotonin in pain modulation, and highlight the importance of genetic studies in the understanding of interindividual differences in sensitivity to pain.
Copyright © 2011 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719351     DOI: 10.1016/j.jpain.2011.02.348

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  23 in total

Review 1.  Genetic basis of pain variability: recent advances.

Authors:  Erin E Young; William R Lariviere; Inna Belfer
Journal:  J Med Genet       Date:  2011-11-05       Impact factor: 6.318

Review 2.  Therapeutic Basis of Clinical Pain Modulation.

Authors:  Daniel R Kirkpatrick; Dan M McEntire; Zakary J Hambsch; Mitchell J Kerfeld; Tyler A Smith; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-05-11       Impact factor: 4.689

3.  Genetic Polymorphisms in the Dopamine Receptor 2 Predict Acute Pain Severity After Motor Vehicle Collision.

Authors:  Yawar J Qadri; Andrey V Bortsov; Danielle C Orrey; Robert A Swor; David A Peak; Jeffrey S Jones; Niels K Rathlev; David C Lee; Robert M Domeier; Phyllis L Hendry; Samuel A Mclean
Journal:  Clin J Pain       Date:  2015-09       Impact factor: 3.442

4.  Association between serotonin transport polymorphisms and postdischarge nausea and vomiting in women following breast cancer surgery.

Authors:  Susan W Wesmiller; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Marguerite Bonaventura; Dana H Bovbjerg; Yvette Conley
Journal:  Oncol Nurs Forum       Date:  2014-03-01       Impact factor: 2.172

5.  Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease.

Authors:  Ellie Jhun; Ying He; Yingwei Yao; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Anesth Analg       Date:  2014-11       Impact factor: 5.108

Review 6.  Clinical Relevance of Joint Hypermobility and Its Impact on Musculoskeletal Pain and Bone Mass.

Authors:  Vito Guarnieri; Marco Castori
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

7.  Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls.

Authors:  Rouslan Sitnikov; Eva Kosek; Isabel Ellerbrock; Angelica Sandström; Jeanette Tour; Silvia Fanton; Diana Kadetoff; Martin Schalling; Karin B Jensen
Journal:  Mol Brain       Date:  2021-05-12       Impact factor: 4.041

8.  Opioid-induced hyperalgesia in community-dwelling adults with chronic pain.

Authors:  W Michael Hooten; Tim J Lamer; Channing Twyner
Journal:  Pain       Date:  2015-06       Impact factor: 7.926

9.  Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients.

Authors:  Wiebke Grashorn; Odette Schunke; Carsten Buhmann; Katarina Forkmann; Sabrina Diedrich; Katharina Wesemann; Ulrike Bingel
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

10.  Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain.

Authors:  W Michael Hooten; William R Hartman; John Logan Black; Heidi J Laures; Denise L Walker
Journal:  BMC Med Genet       Date:  2013-07-30       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.